Identification of Contractile P2Y1, P2Y6, and P2Y12 Receptors in Rat Intrapulmonary Artery Using Selective Ligands

被引:31
|
作者
Mitchell, Callum [1 ]
Syed, Nawazish-i-Husain [1 ]
Tengah, Asrin [1 ]
Gurney, Alison M. [1 ]
Kennedy, Charles [1 ]
机构
[1] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland
关键词
PROTEIN-COUPLED RECEPTOR; VASCULAR SMOOTH-MUSCLE; PULMONARY-CIRCULATION; P2X RECEPTORS; P2-PURINOCEPTOR SUBTYPES; INTERNATIONAL UNION; ADP RECEPTOR; NITRIC-OXIDE; ATP; PHARMACOLOGY;
D O I
10.1124/jpet.112.198051
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
ATP and UDP constrict rat intrapulmonary arteries, but which receptors mediate these actions is unclear. Here, we used selective agonists and antagonists, along with measurements of P2Y receptor expression, to characterize the receptor subtypes involved. Isometric tension was recorded from endotheliumdenuded rat intrapulmonary artery rings (i.d. 200-500 mu m) mounted on a wire myograph. Expression of P2Y receptor subtype expression was determined by using reverse transcription-polymerase chain reaction with receptor-specific oligonucleotide primers. The selective P2Y(1) agonist (N)-methanocarba-2-methylthioadenosine-5'-O-diphosphate (MRS2365) induced small, concentration-dependent contractions that were inhibited by the P2Y(1) antagonist N-6-methyl-2'-deoxyadenosine-3',5'bisphosphate (MRS2179). Contractions evoked by ATP were unaffected by MRS2179, but inhibited by approximately one-third by the P2Y(12) antagonist N-6-(2-methylthiomethyl)-2-(3,3,3-trifluoropropylthio) dichloro-methylene ATP (AR-C69931MX). Combined blockade of P2X1 and P2Y(12) receptors virtually abolished the response to ATP. ADP also evoked contractions that were abolished by AR-C69931MX. The selective P2Y(6) receptor agonist 3-(2-oxo-2-phenylethyl)-UDP (PSB 0474) evoked concentration-dependent contractions and was approximately three times more potent than UDP, but the P2Y(14) agonist UDP-glucose had no effect. Contractions evoked by UDP were inhibited by the P2Y(6) receptor antagonist N,N'-1,4-butanediylbis-N'-(3- isothiocyanatophenyl) thiourea (MRS2578), but not the cysteinyl leukotriene 1 (CysL(1)) antagonist 3-(3-(2-(7-chloro-2-quinolinyl) ethenyl) phenyl)((3-dimethylamino-3-oxopropyl) thio) methyl) thiopropanoic acid (MK571). Higher concentrations of MRS2578 inhibited contractions to KCl, so they were not studied further. mRNA for P2Y(1), P2Y(6), and P2Y(12) receptors was identified. Our working model is that P2Y(12) and P2X(1) receptors are present in rat intrapulmonary arteries and together mediate ATP-induced vasoconstriction. Contractile P2Y(6), but not P2Y(14) or CysLT(1), receptors are also present and are a major site through which UDP evokes constriction.
引用
收藏
页码:755 / 762
页数:8
相关论文
共 50 条
  • [31] Genetic polymorphisms of the platelet receptors P2Y12, P2Y1, and Gl Ilia and response to aspirin and clopidogrel
    Lev, Eli I.
    Patel, Rajnikant T.
    Guthikonda, Sasidhar
    Lopez, David
    Bray, Paul F.
    Kleiman, Neal S.
    THROMBOSIS RESEARCH, 2007, 119 (03) : 355 - 360
  • [32] Methanocarba modification of uracil and adenine nucleotides: High potency of northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim, HS
    Ravi, RG
    Maddileti, S
    Boyer, JL
    Harden, TK
    Marquez, VE
    Jacobson, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U55 - U55
  • [33] GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12
    Zhao, Xuefei
    Cooper, Matthew
    Michael, James V.
    Yarman, Yanki
    Baltz, Aiden
    Chuprun, J. Kurt
    Koch, Walter J.
    McKenzie, Steven E.
    Tomaiuolo, Maurizio
    Stalker, Timothy J.
    Zhu, Li
    Ma, Peisong
    BLOOD ADVANCES, 2022, 6 (15) : 4524 - 4536
  • [34] P2Y1 and P2Y12 receptor heterodimerisation: From recombinant systems to native detection
    Safar, M. A.
    Wood, R.
    Cunningham, M. R.
    Kennedy, C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (16) : 3049 - 3049
  • [35] Pharmacodynamic interplay of the P2Y1, P2Y12, and TxA2 pathways in platelets: The potential of triple antiplatelet therapy with P2Y1 receptor antagonism
    Oestreich, Julie H.
    Ferraris, Suellen P.
    Steinhubl, Steven R.
    Akers, Wendell S.
    THROMBOSIS RESEARCH, 2013, 131 (02) : E64 - E70
  • [36] Machine learning-aided search for ligands of P2Y6 and other P2Y receptors
    Puhl, Ana C.
    Lewicki, Sarah A.
    Gao, Zhan-Guo
    Pramanik, Asmita
    Makarov, Vadim
    Ekins, Sean
    Jacobson, Kenneth A.
    PURINERGIC SIGNALLING, 2024, 20 (06) : 617 - 627
  • [37] P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages
    Bowler, JW
    Bailey, RJ
    North, RA
    Surprenant, A
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (03) : 567 - 575
  • [38] Regulations of mitogen-activated protein kinases in neuronal cells by purinergic receptors P2Y1 and P2Y12
    Wong, YH
    Ho, MKC
    Leung, HY
    Simon, J
    Barnard, EA
    JOURNAL OF NEUROCHEMISTRY, 2003, 87 : 123 - 123
  • [39] Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets
    Jagroop, IA
    Burnstock, G
    Mikhailidis, DP
    PLATELETS, 2003, 14 (01) : 15 - 20
  • [40] Synthesis, characterization and biological evaluation of indomethacin derived thioureas as purinergic (P2Y1, P2Y2, P2Y4, and P2Y6) receptor antagonists
    Bano, Sehrish
    Shabir, Ghulam
    Saeed, Aamer
    Ul-Hamid, Anwar
    Alharthy, Rima D.
    Iqbal, Jamshed
    BIOORGANIC CHEMISTRY, 2021, 116